Immunitybio News - October 2026
🔴 Immunitybio is trading 6.24% down today with no clear company-specific catalyst
Immunitybio is trading 6.24% down at $8.28, alongside broad market weakness; no clear company-specific announcement explaining the October 30 move surfaced. -...
🟢 Immunitybio is trading 10.3% up today amid biotech sector gains; no company catalyst confirmed
Immunitybio is trading at $8.62, up +10.31%, with biotech strength providing context; no confirmed company-specific catalyst was identified for October 27. -...
🟢 Immunitybio is trading 5% up today after FDA expands Anktiva for papillary-only bladder cancer
Immunitybio is trading 5.05% up at $10.29 alongside the FDA’s October 14, 2026 expansion of Anktiva’s approval. - The significant company-specific milestone...
🟢 Immunitybio is trading 10% up today with broader markets higher; catalyst remains unclear
Immunitybio is trading 10.05% higher at $10.21, with no clear company-specific announcement explaining the October 2 move. - The company is scheduled to...
🟢 Immunitybio is trading 7% up today amid broader market gains
Immunitybio is trading at $9.89, up 6.63%, amid broader market strength. - No clear company-specific announcement explaining the rise surfaced in the...